Clinical trial
Mechanisms of Pain Hypersensitivity in a Human Skin Inflammation Model - A Double-blind, Randomized, Placebo-controlled Crossover Study
NCT07092215 is registered in ClinicalTrials.gov with Stefan Heber as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Mechanisms of Pain Hypersensitivity in a Human Skin Inflammation Model - A Double-blind, Randomized, Placebo-controlled Crossover Study
- Lead sponsor
- Stefan Heber
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 17, 2025
- Completion date
- July 11, 2025
- Enrollment
- 42 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.